Bruna Kulmann-Leal

Ms. Bruna Kulmann-Leal

Departamento de Genética e Biologia Molecular, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
PDF file
Joel Henrique EllwangerJoel Henrique Ellwanger
Joel Henrique Ellwanger
BKBruna Kulmann-Leal
Bruna Kulmann-Leal
VKValéria de Lima Kaminski
Valéria de Lima Kaminski
JVJacqueline Valverde Villegas
Jacqueline Valverde Villegas
AVAna B. Gorini da Veiga
Ana B. Gorini da Veiga
José Artur Bogo ChiesJosé Artur Bogo Chies
José Artur Bogo Chies
Amazonian biodiversity is increasingly threatened due to the weakening of policies for combating deforestation, especially in Brazil. Loss of animal and plant species, many not yet known to science, is just one among many negative consequences of Amazon deforestation. Deforestation affects indigenous communities, riverside as well as urban populations, and even planetary health. Amazonia has a prominent role in regulating the Earth's climate, with forest loss contributing to rising regional and global temperatures and intensification of extreme weather events. These climatic conditions are important drivers of emerging infectious diseases, and activities associated with deforestation contribute to the spread of disease vectors. This review presents the main impacts of Amazon deforestation on infectious-disease dynamics and public health from a One Health perspective. Because Brazil holds the largest area of Amazon rainforest, emphasis is given to the Brazilian scenario. Finally, potential solutions to mitigate deforestation and emerging infectious diseases are presented from the perspectives of researchers in different fields.

1 January 2022 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
Joel Henrique EllwangerJoel Henrique Ellwanger
Joel Henrique Ellwanger
PFPhilip Martin Fearnside
Philip Martin Fearnside
MZMarina Ziliotto
Marina Ziliotto
JVJacqueline Valverde Villegas
Jacqueline Valverde Villegas
AVAna B. Gorini da Veiga
Ana B. Gorini da Veiga
José Artur Bogo ChiesJosé Artur Bogo Chies
José Artur Bogo Chies
Zoonotic spillover is a phenomenon characterized by the transfer of pathogens between different animal species. Most human emerging infectious diseases originate from non-human animals, and human-related environmental disturbances are the driving forces of the emergence of new human pathogens. Synthesizing the sequence of basic events involved in the emergence of new human pathogens is important for guiding the understanding, identification, and description of key aspects of human activities that can be changed to prevent new outbreaks, epidemics, and pandemics. This review synthesizes the connections between environmental disturbances and increased risk of spillover events based on the One Health perspective. Anthropogenic disturbances in the environment (e.g., deforestation, habitat fragmentation, biodiversity loss, wildlife exploitation) lead to changes in ecological niches, reduction of the dilution effect, increased contact between humans and other animals, changes in the incidence and load of pathogens in animal populations, and alterations in the abiotic factors of landscapes. These phenomena can increase the risk of spillover events and, potentially, facilitate new infectious disease outbreaks. Using Brazil as a study model, this review brings a discussion concerning anthropogenic activities in the Amazon region and their potential impacts on spillover risk and spread of emerging diseases in this region.

19 October 2022 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
Joel Henrique EllwangerJoel Henrique Ellwanger
Joel Henrique Ellwanger
MZMarina Ziliotto
Marina Ziliotto
BKBruna Kulmann-Leal
Bruna Kulmann-Leal
José Artur Bogo ChiesJosé Artur Bogo Chies
José Artur Bogo Chies

24 March 2020 in International Journal of Immunogenetics
Verified
Journal Article
Open access
PDF file
Joel Henrique EllwangerJoel Henrique Ellwanger
Joel Henrique Ellwanger
VKValéria de Lima Kaminski
Valéria de Lima Kaminski
ARAndressa Gonçalves Rodrigues
Andressa Gonçalves Rodrigues
BKBruna Kulmann-Leal
Bruna Kulmann-Leal
José Artur Bogo ChiesJosé Artur Bogo Chies
José Artur Bogo Chies
The CCR5 molecule was reported in 1996 as the main HIV‐1 co‐receptor. In that same year, the CCR5Δ32 genetic variant was described as a strong protective factor against HIV‐1 infection. These findings led to extensive research regarding the CCR5, culminating in critical scientific advances, such as the development of CCR5 inhibitors for the treatment of HIV infection. Recently, the research landscape surrounding CCR5 has begun to change. Different research groups have realized that, since CCR5 has such important effects in the chemokine system, it could also affect other different physiological systems. Therefore, the effect of reduced CCR5 expression due to the presence of the CCR5Δ32 variant began to be further studied. Several studies have investigated the role of CCR5 and the impacts of CCR5Δ32 on autoimmune and inflammatory diseases, various types of cancer, and viral diseases. However, the role of CCR5 in diseases caused by bacteria and parasites is still poorly understood. Therefore, the aim of this article is to review the role of CCR5 and the effects of CCR5Δ32 on bacterial (brucellosis, osteomyelitis, pneumonia, tuberculosis and infection by Chlamydia trachomatis) and parasitic infections (toxoplasmosis, leishmaniasis, Chagas disease and schistosomiasis). Basic information about each of these infections was also addressed. The neglected role of CCR5 in fungal disease and emerging studies regarding the action of CCR5 on regulatory T cells are briefly covered in this review. Considering the “renaissance of CCR5 research,” this article is useful for updating researchers who develop studies involving CCR5 and CCR5Δ32 in different infectious diseases.

1 June 2023 in Pollutants
Verified
Journal Article
Open access
PDF file
MZMarina Ziliotto
Marina Ziliotto
BKBruna Kulmann-Leal
Bruna Kulmann-Leal
ARAlice Roitman
Alice Roitman
José Artur Bogo ChiesJosé Artur Bogo Chies
José Artur Bogo Chies
Joel Henrique EllwangerJoel Henrique Ellwanger
Joel Henrique Ellwanger
The Brazilian Pampa biome covers half of Rio Grande do Sul state, in the extreme south of Brazil, creating an ecotone zone with the Atlantic Forest and bordering Pampa’s territory belonging to Uruguay and Argentina. Pampa is a non-forest biome mainly composed of grasslands and mosaics of grassland-forest vegetation. This biome shows significant animal and plant diversity, contributing to the maintenance of important ecosystem services, including CO2 capture, pollination, and water cycle regulation. However, forestry plantations, inappropriate cattle ranching, mining activities, unplanned urbanization, and the cultivation of monocultures (soy, rice, tobacco, and other cash crops) significantly threaten the conservation of the Pampa biome. A major problem observed in the Pampa, due to the great connection of this biome with agricultural areas, is pesticide pollution, which significantly affects the health of humans and animals that occupy the region. A robust body of evidence indicates that aquatic and terrestrial ecosystems in the Brazilian Pampa are extensively contaminated with pesticides, as indicated by studies involving animal biomarkers and pesticide analyses performed on water and soil samples. Human studies also suggest that pesticides affect different body systems, facilitating the onset of various chronic diseases. Brazil’s conservation actions and policies have a special focus on forest ecosystems, neglecting non-forest biomes and thus aggravating the problems related to Pampa’s conservation. In this article, we discuss some problems caused by pesticide pollution in the Brazilian Pampa, drawing attention to the need for intensification of policies focused on the promotion of human and environmental health. Finally, we suggest the bioecological bioeconomy as an alternative for Rio Grande do Sul to progress its economic development but with less dependency on detrimental activities to the Pampa biome.

4 January 2023 in Viruses
Verified
Journal Article
Open access
PDF file
Joel Henrique EllwangerJoel Henrique Ellwanger
Joel Henrique Ellwanger
BKBruna Kulmann-Leal
Bruna Kulmann-Leal
MZMarina Ziliotto
Marina Ziliotto
José Artur Bogo ChiesJosé Artur Bogo Chies
José Artur Bogo Chies
Genome integrity is critical for proper cell functioning, and chromosome instability can lead to age-related diseases, including cancer and neurodegenerative disorders. Chromosome instability is caused by multiple factors, including replication stress, chromosome missegregation, exposure to pollutants, and viral infections. Although many studies have investigated the effects of environmental or lifestyle genotoxins on chromosomal integrity, information on the effects of viral infections on micronucleus formation and other chromosomal aberrations is still limited. Currently, HIV infection is considered a chronic disease treatable by antiretroviral therapy (ART). However, HIV-infected individuals still face important health problems, such as chronic inflammation and age-related diseases. In this context, this article reviews studies that have evaluated genomic instability using micronucleus assays in the context of HIV infection. In brief, HIV can induce chromosome instability directly through the interaction of HIV proteins with host DNA and indirectly through chronic inflammation or as a result of ART use. Connections between HIV infection, immunosenescence and age-related disease are discussed in this article. The monitoring of HIV-infected individuals should consider the increased risk of chromosome instability, and lifestyle interventions, such as reduced exposure to genotoxins and an antioxidant-rich diet, should be considered. Therapies to reduce chronic inflammation in HIV infection are needed.